Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 1–50 of 1,618 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05212246	Basal Cell Carcinoma Chemoprevention Trial(B3C)	not yet recruiting	Phase 3	1,630	VA Office of Research and DevelopmentFED	1	Sep 29, 2026	clinicaltrials
NCT07005297	Clinical Genetics Branch Eligibility Screening Survey	not yet recruiting	—	1,000	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials